BBA
PMVP icon

Baker Bros. Advisors’s PMV Pharmaceuticals PMVP Stock Holding History

Baker Bros. Advisors’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-322,024
Closed -$486K – 96
2024
Q4 		$486K Hold
322,024
– – 0.01% 91
2024
Q3 		$480K Hold
322,024
– – 0.01% 89
2024
Q2 		$522K Hold
322,024
– – 0.01% 90
2024
Q1 		$547K Hold
322,024
– – 0.01% 81
2023
Q4 		$998K Hold
322,024
– – 0.01% 77
2023
Q3 		$1.98M Hold
322,024
– – 0.01% 87
2023
Q2 		$2.02M Hold
322,024
– – 0.01% 95
2023
Q1 		$1.54M Hold
322,024
– – 0.01% 94
2022
Q4 		$2.8M Hold
322,024
– – 0.02% 92
2022
Q3 		$3.83M Buy
+322,024
New +$4.65M 0.03% 88

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baker Bros. Advisors's PMVP Position: Q1 2025 in Review

Baker Bros. Advisors sold out of PMV Pharmaceuticals (PMVP) in Q1 2025, closing a stake of 322,024 shares — an estimated $486K sold.

Baker Bros. Advisors first reported a position in PMVP in Q3 2022 and held it in 10 quarters. The position peaked at $3.83M in Q3 2022. 55 funds tracked by Wall St. Rank hold PMVP as of Q1 2025.

  • Baker Bros. Advisors reported no remaining PMV Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Baker Bros. Advisors sold 322,024 PMV Pharmaceuticals shares in Q1 2025, an estimated $486K.
  • Baker Bros. Advisors first reported a position in PMV Pharmaceuticals in Q3 2022 and held it in 10 quarters.
  • Baker Bros. Advisors's PMV Pharmaceuticals position peaked at $3.83M in Q3 2022.
  • 55 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q1 2025.

Based on Baker Bros. Advisors's 13F filing for Q1 2025, filed 15 May 2025.